We are live on ! Find out more
TXMD icon

TherapeuticsMD
TXMD

154 hedge funds and large institutions have $204M invested in TherapeuticsMD in 2021 Q2 according to their latest regulatory filings, with 17 funds opening new positions, 49 increasing their positions, 38 reducing their positions, and 23 closing their positions.

New
Increased
Maintained
Reduced
Closed

133% more call options, than puts

Call options by funds: $2.01M | Put options by funds: $865K

29% more repeat investments, than reductions

Existing positions increased: 49 | Existing positions reduced: 38

0.04% less ownership

Funds ownership: 0.91% → 0.87% (-0.04%)

4% less funds holding

Funds holding: 160 → 154 (-6)

14% less capital invested

Capital invested by funds: $237M → $204M (-$33.1M)

26% less first-time investments, than exits

New positions opened: 17 | Existing positions closed: 23

Holders
154
Holders Change
-6
Holders Change %
-3.75%
% of All Funds
2.68%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
17
Increased
49
Reduced
38
Closed
23
Calls
$2.01M
Puts
$865K
Net Calls
+$1.15M
Net Calls Change
+$132K

Top Buyers

Rank Fund Capital Flow
1
Morgan Stanley
Morgan Stanley
New York
+$3.49M
2
N
Nuveen
North Carolina
+$2.39M
3
State Street
State Street
Massachusetts
+$2.2M
4
Ameriprise
Ameriprise
Minnesota
+$1.46M
5
Citadel Advisors
Citadel Advisors
Florida
+$761K

Top Sellers

Rank Fund Capital Flow
1
PA
Perceptive Advisors
New York
-$3.69M
2
BlackRock
BlackRock
New York
-$3.34M
3
Axa
Axa
France
-$2.59M
4
LCM
Laurion Capital Management
New York
-$2.19M
5
Goldman Sachs
Goldman Sachs
New York
-$1.91M
Name Holding Trade Value Shares
Change 		Change in
Stake
CIBC Asset Management
126
CIBC Asset Management
Ontario, Canada
$15K – – –
MSWMA
127
Market Street Wealth Management Advisors
Indiana
$15K – – –
PAMU
128
Pictet Asset Management (UK)
United Kingdom
$14K – – –
KAS
129
Kestra Advisory Services
Texas
$14K +$14K +231 New
Mackenzie Financial
130
Mackenzie Financial
Ontario, Canada
$14K +$14.7K +242 New
Osaic Holdings
131
Osaic Holdings
Arizona
$13K -$61 -1 -0.4%
AWE
132
Avidian Wealth Enterprises
Texas
$13K – – –
BFA
133
Beaumont Financial Advisors
Massachusetts
$12K -$30.3K -500 -71%
FCMT
134
Founders Capital Management (Texas)
Texas
$12K +$12.1K +200 New
DI
135
DFPG Investments
Utah
$11K – – –
PCM
136
Penserra Capital Management
California
$10K +$182 +3 +2%
Northwestern Mutual Wealth Management
137
Northwestern Mutual Wealth Management
Wisconsin
$8K – – –
TFO
138
Tarbox Family Office
California
$8K +$8.48K +140 New
HNB
139
Huntington National Bank
Ohio
$7K – – –
PNC Financial Services Group
140
PNC Financial Services Group
Pennsylvania
$3K -$2.6K -43 -49%
Carson Wealth (CWM LLC)
141
Carson Wealth (CWM LLC)
Nebraska
$2K – – –
HI
142
Harbour Investments
Wisconsin
$2K – – –
MCM
143
MV Capital Management
Maryland
$2K – – –
TWA
144
TCI Wealth Advisors
Arizona
$2K – – –
TFS
145
TrustCore Financial Services
Tennessee
$1K -$485 -8 -30%
Daiwa Securities Group
146
Daiwa Securities Group
Japan
$1K – – –
EWM
147
Edge Wealth Management
New York
$1K – – –
HR
148
Howe & Rusling
New York
$1K – – –
SPIA
149
Steward Partners Investment Advisory
New York
$1K – – –
BFG
150
Baron Financial Group
New Jersey
$952 – – –
4 5
6
7 8

TXMD Hedge Fund Activity: Q2 2021 in Review

154 of the 5,746 institutional investors tracked by Wall St. Rank reported a position in TherapeuticsMD (TXMD) for Q2 2021, worth a combined $204M — down 14% from $237M a quarter earlier.

Sellers outnumbered buyers: 23 funds closed out of TXMD and 17 opened new positions — a net loss of 6 holders — while 38 trimmed existing stakes and 49 added.

The largest buyer was Morgan Stanley, adding an estimated $3.49M. The largest seller was Perceptive Advisors, exiting entirely with an estimated $3.69M sold.

  • 154 institutional investors held TherapeuticsMD (TXMD) as of Q2 2021, down from 160 in Q1 2021.
  • Funds reported $204M of TherapeuticsMD stock for Q2 2021, down 14% quarter-over-quarter.
  • 17 funds opened new TherapeuticsMD positions in Q2 2021 and 23 closed out, a net change of -6 holders.
  • The largest TherapeuticsMD buyer in Q2 2021 was Morgan Stanley, an estimated $3.49M added.
  • The largest TherapeuticsMD seller in Q2 2021 was Perceptive Advisors, an estimated $3.69M sold.

Based on aggregated 13F filings for Q2 2021.